dr. kim on role of frontline immunotherapy in advanced hcc
Published 5 years ago • 222 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:37
dr. kim on the potential of ramucirumab in advanced hcc
-
1:22
dr. kim on immunotherapy in crc
-
1:35
dr. el-khoueiry on evolving role of immunotherapy in hcc
-
4:14
imbrave150 trial: frontline treatment of advanced hcc
-
0:53
dr. abou-alfa on the role of immunotherapy in hcc
-
7:13
immunotherapy in hcc
-
1:03
dr. musher discusses the role of regorafenib in advanced hcc
-
1:18
dr. kim on the evolving treatment landscape of advanced hcc
-
4:01
hepatocellular carcinoma: future role of immunotherapy
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
2:13
richard s. finn, md, offers opinion on the role of frontline atezolizumab bevacizumab in hcc
-
1:16
dr. el-khoueiry on the frontline treatment landscape in hcc
-
3:27
immunotherapy in second-line metastatic hcc
-
0:51
dr. seymour on role of ibrutinib in cll
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
1:04
dr. singal on the potential for immunotherapy in hcc
-
1:50
dr. tim f. greten on immunotherapy in hcc
-
1:38
dr. el-khoueiry discusses research on biomarkers in hcc